Literature DB >> 30155784

Immunodeficiency in a Child with Alström Syndrome.

Taha Resid Ozdemir1, Neslihan Edeer Karaca2, Jan Davis Marshall3, Necil Kutukculer2, Guzide Aksu2, Riza Koksal Ozgul4, Aysegul Ozanturk4, Esra Isik2, Bilcag Akgun2, Hamiyet Hekimci Ozdemir2, Sukran Darcan2, Ferda Ozkinay2,5, Ozgur Cogulu6,7.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30155784     DOI： 10.1007/s12098-018-2740-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  5 in total

1.  Proteomic characterization of the human centrosome by protein correlation profiling.

Authors:  Jens S Andersen; Christopher J Wilkinson; Thibault Mayor; Peter Mortensen; Erich A Nigg; Matthias Mann
Journal:  Nature       Date:  2003-12-04       Impact factor: 49.962

2.  Alström syndrome.

Authors:  Jan D Marshall; Sebastian Beck; Pietro Maffei; Jürgen K Naggert
Journal:  Eur J Hum Genet       Date:  2007-10-17       Impact factor: 4.246

3.  Alström syndrome: genetics and clinical overview.

Authors:  Jan D Marshall; Pietro Maffei; Gayle B Collin; Jürgen K Naggert
Journal:  Curr Genomics       Date:  2011-05       Impact factor: 2.236

4.  ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis.

Authors:  Elisabetta Zulato; Francesca Favaretto; Caterina Veronese; Stefano Campanaro; Jan D Marshall; Sara Romano; Anna Cabrelle; Gayle B Collin; Barbara Zavan; Anna S Belloni; Enrica Rampazzo; Jürgen K Naggert; Giovanni Abatangelo; Nicola Sicolo; Pietro Maffei; Gabriella Milan; Roberto Vettor
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

5.  Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes.

Authors:  Tom Hearn; Cosma Spalluto; Victoria J Phillips; Glenn L Renforth; Nane Copin; Neil A Hanley; David I Wilson
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.